Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1999-07-21
2000-10-24
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514533, 560 84, 560193, A61K 31235, C07C 6976, C07C 6952
Patent
active
061368547
ABSTRACT:
Cyclopentenone derivative having a structure of 5-(R.sub.1 COO--)-4-(R.sub.2 COO--)--substituted 2-cyclopenten-1-one (R.sub.1 and R.sub.2 are some or different and each is alkyl group, alkenyl group or aryl group) or an optically active substance thereof; a method for the manufacture of the cyclopentenone derivative by the reaction of 4,5-dihydroxy-2-cyclopenten-1-one with the corresponding carboxylic acid or a reactive derivative thereof; and anticancer agent, apoptosis-inducing agent and antibacterial agent containing said derivative.
REFERENCES:
Ahmad, T., On the formation of reductiv acid from pentoses or hexuronic acids Carbohydrates Res., vol. 247, pp. 217-222, 1993.
Amos B. Smith, "Stereocontrolled total synthesis of (.+-.)-pentenomycins. I-III, their epimers, and dehydropentenomycin I," J. Organ. Chem., vol. 47, No. 10, pp. 1855-1869 (1982).
International Preliminary Examination Report for International Application No. PCT/JP98/00817, Feb. 25, 1999.
Ikai Katsushige
Kato Ikunoshin
Kobayashi Eiji
Koyama Nobuto
Geist Gary
Maier Leigh C.
Takara Shuzo Co.
LandOfFree
Cyclopentenone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopentenone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentenone derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1964638